GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bionoid Pharma Inc (OTCPK:BINP) » Definitions » Total Liabilities

Bionoid Pharma (Bionoid Pharma) Total Liabilities : $2.13 Mil (As of Mar. 2011)


View and export this data going back to 2007. Start your Free Trial

What is Bionoid Pharma Total Liabilities?

Bionoid Pharma's Total Liabilities for the quarter that ended in Mar. 2011 was $2.13 Mil.

Bionoid Pharma's quarterly Total Liabilities increased from Sep. 2010 ($2.07 Mil) to Dec. 2010 ($2.20 Mil) but then declined from Dec. 2010 ($2.20 Mil) to Mar. 2011 ($2.13 Mil).

Bionoid Pharma's annual Total Liabilities declined from Dec. 2008 ($1.92 Mil) to Dec. 2009 ($1.89 Mil) but then increased from Dec. 2009 ($1.89 Mil) to Dec. 2010 ($2.20 Mil).

Bionoid Pharma Total Liabilities Historical Data

The historical data trend for Bionoid Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bionoid Pharma Total Liabilities Chart

Bionoid Pharma Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10
Total Liabilities
0.61 1.36 1.92 1.89 2.20

Bionoid Pharma Quarterly Data
Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.08 2.12 2.07 2.20 2.13

Bionoid Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Bionoid Pharma's Total Liabilities for the fiscal year that ended in Dec. 2010 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.201+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=2.20

Total Liabilities=Total Assets (A: Dec. 2010 )-Total Equity (A: Dec. 2010 )
=1.33--0.871
=2.20

Bionoid Pharma's Total Liabilities for the quarter that ended in Mar. 2011 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=2.127+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=2.13

Total Liabilities=Total Assets (Q: Mar. 2011 )-Total Equity (Q: Mar. 2011 )
=0.647--1.48
=2.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bionoid Pharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Bionoid Pharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bionoid Pharma (Bionoid Pharma) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bionoid Pharma Inc (OTCPK:BINP) » Definitions » Total Liabilities
Comparable Companies
DXTR NURO PEYE ECIA RSCF SSKN SOAN ASNB UNISQ WHSI QTXB LSE:AKR SKLN UEEC NEPH STXS REPR ATEC WAR:MMD DXR
Traded in Other Exchanges
N/A
Address
433 N Camden Dr, Beverly Hills, CA, USA, 90210
Website
https://www.bionoidpharma.com
Bionoid Pharma Inc is a cannabis company that cultivates, extracts, tests, and distributes organic hemp, cannabinoid, and related products. Its products aid in decreasing pain, improving recovery time, enhancing performance, and enhance physical well-being.